Welcome to the latest issue of Pharmaceutical Technology Focus magazine
The successful launch of mRNA vaccines during the Covid-19 pandemic has not only spurred mRNA-related research across interdisciplinary groups, but also further validated the use of lipid nanoparticles as delivery approaches. This issue's cover story delves into how the interest around exploring nanotechnology for drug delivery solutions has recently grown.
Don’t miss an exclusive interview looking at the progress made in the decade since the first chimeric antigen receptor (CAR)-T therapy was successfully tested in a patient.
Also, this month’s thematic take digs into the varied facets of Environmental, Social and Governance (ESG)-related issues in the pharmaceutical industry.
All this and the latest pharma industry news, comment, and analysis from GlobalData.
Manasi Vaidya, editor